Streamline Health Solutions (NASDAQ:STRM) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock.

Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Stock Performance

STRM stock opened at $2.69 on Friday. The company has a market capitalization of $11.35 million, a P/E ratio of -0.54 and a beta of 1.64. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61. The business has a 50-day moving average price of $3.37 and a 200 day moving average price of $5.52. Streamline Health Solutions has a 1-year low of $1.85 and a 1-year high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The company had revenue of $4.48 million for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.